Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Byrd

Showing results (511-520 of 1,058) with videos related to

Pageof 106
Sort By:
Blood|September 1, 2007
FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphomaQing Liu, Xiaobin Zhao, Frank Frissora, et al.
Blood|May 4, 2006
Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemiaAmy J Johnson, David M Lucas, Natarajan Muthusamy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2013
A pharmacokinetic/pharmacodynamic model of tumor lysis syndrome in chronic lymphocytic leukemia patients treated with flavopiridolJia Ji, Diane R Mould, Kristie A Blum, et al.
Cancer Chemotherapy and Pharmacology|March 1, 2015
The effect of food on the pharmacokinetics of oral ibrutinib in healthy participants and patients with chronic lymphocytic leukemiaJan de Jong, Juthamas Sukbuntherng, Donna Skee, et al.
Cancers|June 18, 2020
Cotargeting of XPO1 Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Acute Myeloid LeukemiaLindsey T Brinton, Steven Sher, Katie Williams, et al.
Blood|November 25, 2003
Hu1D10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cellsAndrew P Mone, Peng Huang, Helene Pelicano, et al.
Blood|July 13, 2000
Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignanciesI W Flinn, J C Byrd, C Morrison, et al.
British Journal of Haematology|October 24, 2007
Rituximab and 17-allylamino-17-demethoxygeldanamycin induce synergistic apoptosis in B-cell chronic lymphocytic leukaemiaAmy J Johnson, Amy J Wagner, Carolyn M Cheney, et al.
Blood|June 26, 2004
FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemiaThomas S Lin, Ian W Flinn, Rama Modali, et al.
Cancer|August 8, 2013
A phase 2 trial of extended induction epratuzumab and rituximab for previously untreated follicular lymphoma: CALGB 50701Barbara W Grant, Sin-Ho Jung, Jeffrey L Johnson, et al.
Pageof 106

Showing results (511-520 of 1,058) with videos related to

Sort By:
Pageof 106
Blood|September 1, 2007
FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphomaQing Liu, Xiaobin Zhao, Frank Frissora, et al.
Blood|May 4, 2006
Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemiaAmy J Johnson, David M Lucas, Natarajan Muthusamy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2013
A pharmacokinetic/pharmacodynamic model of tumor lysis syndrome in chronic lymphocytic leukemia patients treated with flavopiridolJia Ji, Diane R Mould, Kristie A Blum, et al.
Cancer Chemotherapy and Pharmacology|March 1, 2015
The effect of food on the pharmacokinetics of oral ibrutinib in healthy participants and patients with chronic lymphocytic leukemiaJan de Jong, Juthamas Sukbuntherng, Donna Skee, et al.
Cancers|June 18, 2020
Cotargeting of XPO1 Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Acute Myeloid LeukemiaLindsey T Brinton, Steven Sher, Katie Williams, et al.
Blood|November 25, 2003
Hu1D10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cellsAndrew P Mone, Peng Huang, Helene Pelicano, et al.
Blood|July 13, 2000
Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignanciesI W Flinn, J C Byrd, C Morrison, et al.
British Journal of Haematology|October 24, 2007
Rituximab and 17-allylamino-17-demethoxygeldanamycin induce synergistic apoptosis in B-cell chronic lymphocytic leukaemiaAmy J Johnson, Amy J Wagner, Carolyn M Cheney, et al.
Blood|June 26, 2004
FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemiaThomas S Lin, Ian W Flinn, Rama Modali, et al.
Cancer|August 8, 2013
A phase 2 trial of extended induction epratuzumab and rituximab for previously untreated follicular lymphoma: CALGB 50701Barbara W Grant, Sin-Ho Jung, Jeffrey L Johnson, et al.
Pageof 106